After a Texas federal court judge issued a ruling this week that could ban the use of abortion pills nationwide, two Democratic-led states have begun stockpiling the drugs. As the Biden administration appeals U.S. District Judge Matthew Kacsmaryk’s ruling on Friday that the FDA’s approval of mifepristone 23 years ago was illegal, California Governor Gavin Newsom said Monday that his state had obtained approximately 2 million misoprostol pills and that Massachusetts had stockpiled 15,000 doses of mifepristone.
California Governor Gavin Newsom claimed in a press release that the state purchased a stockpile of an alternative medical abortion pill in response to an “extremist ban” on a medical abortion drug. No matter how many fanatics try to ban abortion services, we will not back down. Medical abortion is still legal in the Golden State.
According to the announcement, California purchased the misoprostol supply in preparation for Kacsmaryk’s verdict.
On Monday, Governor Maura Healy told reporters that “abortion will remain safe, legal and accessible here in Massachusetts” and that the state’s stockpile of 15,000 pills would be enough to last nearly a year.
Healy was joined by Senator Elizabeth Warren, Representative Ayanna Presley and Massachusetts Attorney General Andrea Campbell. They assured the public that the Biden administration would take action to protect women’s access to abortion.
They can take many different actions,” Warren added. And from the outset, they began to appeal the verdict in court. This radical Texas judge reminds us that Roe v. Wade will be on the ballot in four years.
The Biden administration argued Monday that the lawsuit challenging the 2000 FDA approval of mifepristone is “grossly ill-timed” and that the group of anti-abortion doctors and medical associations that targeted access to the drug n didn’t have the legal status to challenge the FDA approval of mifepristone. , which they neither take nor prescribe.
On the same day, however, a federal district judge in Washington issued a separate order that prevents the FDA from changing the status quo regarding the availability of mifepristone in 16 states and the District of Columbia, further complicating the legal situation. . Those states and the District of Columbia filed a lawsuit against the Biden administration in February to prevent the availability of the drug from being severely curtailed.
To better understand its responsibilities under the order, the Department of Justice contacted the relevant court for clarification.